Dexamethasone and tadalafil prophylaxis prevents both excessive pulmonary constriction and high altitude pulmonary edema in susceptible subjects Source: Eur Respir J 2004; 24: Suppl. 48, 110s Year: 2004
Keratinocyte growth factor2 pretreatment significantly reduces stress failure on high altitude pulmonary edema Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury Year: 2010
Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001
Combination of budesonide and formoterol is more effective in inhibiting GM-CSF production by bronchial epithelial cells than either drug alone Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003
The influence of β2 adrenoceptor polymorphisms on the response to formoterol, montelukast or higher dose budesonide in patients with uncontrolled asthma despite low dose budesonide Source: Annual Congress 2004 - Further pharmacological and clinical evidence for using long-acting β-agonists with inhaled corticosteroids Year: 2004
Efficacy of low dose theophylline in patient with bronchial asthma - anti-inflammatory effect Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003
The effect of long term low dose azithromycin on symptoms and lung function in pulmonary sarcoidosis Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2 -agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
Inhaled budesonide suppresses airway and systemic eosinophilic inflammation in COPD. No predictive value of a prednisolone test treatment Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005
Effect of combination fluticasone propionate and salmeterol diskhaler in treatment of moderate to severe asthma: comparison of initial high dose, constant medium dose and placebo Source: Eur Respir J 2001; 18: Suppl. 33, 123s Year: 2001
Dexamethasone prevents high altitude pulmonary edema without effects on nasal potentials Source: Eur Respir J 2004; 24: Suppl. 48, 327s Year: 2004
Efficacy of short-term high dose predonisolone therapy in acute exacerbation of bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 71s Year: 2001
Influence of formoterol alone and its fixed combination with budesonide on airway responsiveness and airway inflammation induced by repeated low dose allergen challenge Source: Eur Respir J 2007; 30: Suppl. 51, 749s Year: 2007
Utility of high dose inhaled fluticasone therapy for the early management of acute exacerbations of asthma Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009
The therapeutic effects of zafirlukast on COPD induced pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001
Anti-inflammatory effect and clinical efficacy of concomitant treatments to steroid inhaler in bronchial asthma: montelukast versus salmeterol Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006
Topical evaluation of growth factors in arterial remodeling in patients with COPD and osteoporosis Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020
Budesonide and formoterol in mild persistent asthma compared with doubling the dose of budesonide - a cost-effectiveness analysis Source: Eur Respir J 2001; 18: Suppl. 33, 517s Year: 2001
High doses of inhaled formoterol have less systemic effect in asthmatic children than high doses of inhaled terbutaline Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003
Three month treatment with formoterol in mild asthma: efficacy and side effects Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001